Učitavanje...
Reimbursement of licensed cell and gene therapies across the major European healthcare markets
OBJECTIVE: The aim of this research is to identify the pricing, reimbursement, and market access (P&R&MA) considerations most relevant to advanced therapy medicinal products (ATMPs) in the Big5EU, and to inform their manufacturers about the key drivers for securing adoption at a commercially...
Spremljeno u:
| Izdano u: | J Mark Access Health Policy |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Co-Action Publishing
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4802687/ https://ncbi.nlm.nih.gov/pubmed/27123175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/jmahp.v3.29321 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|